Skip to main content
SpringerLink
Log in

Apparent mineralocorticoid excess syndromes

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Biglieri E.G., Kater C.E. Steroid characteristics of mineralocorticoid adrenocortical hypertension. Clin. Chem. 37: 1843, 1991.

    PubMed  CAS  Google Scholar 

  2. Mantero F., Armanini D., Boscaro M., Carpene G., Fallo F., Opocher G., Rocco S., Scaroni C., Sonino N. Steroids and hypertension. J. Steroid. Biochem. Mol. Biol. 40: 35, 1991.

    PubMed  CAS  Google Scholar 

  3. Fraser R., Davies D.L., Connell J.M.C. Hormones and hypertension. Clin. Endocrinol. 31: 701, 1989.

    CAS  Google Scholar 

  4. Melby J.C. Clinical Review 1; Endocrine Hypertension. J. Clin. Endocrinol. Metab. 69: 697, 1989.

    PubMed  CAS  Google Scholar 

  5. Arriza J.L., Weinberger C., Cerelli G., Glaser T.M., Handelin B.L., Housman D.E., Evans R.M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237: 268, 1987.

    PubMed  CAS  Google Scholar 

  6. Stewart P.M., Wallace A.M., Atherden S.M., Shearing C.H., Edwards C.R.W. Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11ß-hydroxysteroid dehydrogenase activity in man. Clin. Sci. 78: 49, 1990.

    PubMed  CAS  Google Scholar 

  7. Ulick S., Levine L.S., Gunczler P., Zanconato G., Ramirez L.C., Rauh W., Rösier A., Bradlow H.L., New M.L. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49: 757, 1979.

    PubMed  CAS  Google Scholar 

  8. Whitworth J.A., Stewart P.M., Burt D., Atherden S.M., Edwards C.R.W. The kidney is the major site of cortisone production in man. Clin. Endocrinol. 31: 355, 1989.

    CAS  Google Scholar 

  9. Orth D.N., Kovacs W.J., Debold C.R. The adrenal cortex. In: Wilson J.D., Foster D.W. (Eds.), Williams Text Book of Endocrinology, (Ed. 8.) W.B. Saunders company, Philadelphia, 1992, p. 489.

    Google Scholar 

  10. Shackleton C.H.L., Stewart P.M. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri E.G., Melby J.C. (Eds.), Endocrine hypertension. Raven Press, New York, 1990, p. 155.

    Google Scholar 

  11. Amelung D., Hübener H.J., Roka L., Meyerheim G. Conversion of cortisone to compound F. J. Clin. Endocrinol. Metab. 13: 1125, 1953.

    PubMed  CAS  Google Scholar 

  12. Monder C., White P.C. 11ß-hydroxysteroid dehydrogenase. Vitam. Horm. 47: 187, 1993.

    PubMed  CAS  Google Scholar 

  13. Stewart P.M. 11ß-hydroxysteroid dehydrogenase. In: Sheppard M.C., Stewart P.M. (Eds.), Baillière’s Clinical Endocrinology and Metabolism. Baillière Tindall, London, 1994, vol. 8, No. 2, p. 357.

    Google Scholar 

  14. Lakshmi V., Monder C. Purification and characterization of the corticosteroid 11ß-dehydrogenase component of the rat liver 11ß-hydroxysteroid dehydrogenase complex. Endocrinology 123: 2390, 1988.

    PubMed  CAS  Google Scholar 

  15. Agarwal A.K., Tusie-Luna M.T., Monder C., White P.C. Expression of 11ß-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol. Endocrinol. 4: 1827, 1990.

    PubMed  CAS  Google Scholar 

  16. Monder C., Lakshmi V. Corticosteroid 11ß-dehydrogenate of rat tissues: immunological studies. Endocrinology. 126: 2435, 1990.

    PubMed  CAS  Google Scholar 

  17. Agarwal A.K., Monder C., Eckstein B., White P.C. Cloning and expression of rat cDNA encoding corticosteroid 11ß-dehydrogenase. J. Biol. Chem. 264: 18939, 1989.

    PubMed  CAS  Google Scholar 

  18. Krozowski Z., Stuchbery S., White P., Monder C., Funder J.W. Characterization of 11ß-hydroxysteroid dehydrogenase gene expression: indication of multiple unique forms of messenger ribonucleic acid in the rat kidney. Endocrinology. 127: 3009, 1990.

    PubMed  CAS  Google Scholar 

  19. Whorwood C.B., Franklyn J.A., Sheppard M.C., Stewart P.M. Tissue localization of 11ß-hydroxysteroid dehydrogenase and its relationship to the glucocorticoid receptor. J. Steroid. Biochem. Mol. Biol. 41: 21, 1992.

    PubMed  CAS  Google Scholar 

  20. Tannin G.M., Agarwal A.K. Monder C., New M.I., White P.C. The human gene for 11ß-hydroxysteroid dehydrogenase. J. Biol. Chem. 266: 16653, 1991.

    PubMed  CAS  Google Scholar 

  21. Stewart P.M., Murry B.A., Mason J.I. Human kidney 11ß-hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J. Clin. Endocrinol. Metab. 79: 480, 1994.

    PubMed  CAS  Google Scholar 

  22. Whorwood C.B., Mason J.I., Ricketts M.L., Howie A.J., Stewart P.M. Detection of human 11ß-hydroxysteroid dehydrogenase isoforms using reverse-transcriptase-poly-merase chain reaction and localization of the type 2 isoform to renal collecting ducts. Mol. Cell. Endocrinol. 110: R7, 1995.

    PubMed  CAS  Google Scholar 

  23. Edwards C.R.W., Stewart P.M., Burt D., Brett L., McIntyre M.A., Sutanto W.S., de Kloet E.R., Monder C. Localisation of 11ß-hydroxysteroid dehydrogenase-tissue specific protector of the mineralocorticoid receptor. Lancet 11: 986, 1988.

    Google Scholar 

  24. Rundle S.E., Funder J.W., Lakshmi V., Monder C. The intrarenal localization of mineralocorticoid receptors and 11ß-dehydrogenase: immunocyto-chemical studies. Endocrinology. 125: 1700, 1989.

    PubMed  CAS  Google Scholar 

  25. Stewart P.M., Whorwood C.B., Barber P., Gregory J., Monder C., Franklyn J.A., Sheppard M.C. Localization of renal 11ß-dehydrogenase by in situ hybridization: autocrine not paracrine protector of the mineralocorticoid receptor. Endocrinology. 128: 2129, 1991.

    PubMed  CAS  Google Scholar 

  26. Whorwood C.B., Barber P.C., Gregory J., Sheppard M.C., Stewart P.M. 11ß-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in the rat colon. Am. J. Physiol. 264: E951, 1993.

    PubMed  CAS  Google Scholar 

  27. Krozowski Z., Wendell K., Ahima R., Harlan R. Type I corticosteroid receptor-like immunoreactivity in the rat salivary glands and distal colon: modulation by corticosteroids. Mol. Cell. Endocrinol. 85: 31, 1992.

    Google Scholar 

  28. Mercer W.R., Krozowski Z.S. Localization of an 11ß hydroxysteroid dehydrogenase activity to the distal nephron. Evidence for the existence of two species of dehydrogenase in the rat kidney. Endocrinology. 130: 540, 1992.

    CAS  Google Scholar 

  29. Walker B.R., Campbell J.C., Williams B.C., Edwards C.R.W. Tissue-specific distribution of the NAD+-dependent isoform of 11ß-hydroxysteroid dehydrogenase. Endocrinology. 131: 970, 1992.

    PubMed  CAS  Google Scholar 

  30. Rusvai E., Náray-Fejes-Tóth A. A new isoform of 11ß-hydroxysteroid dehydrogenase in aldosterone target cells. J. Biol. Chem. 268: 10717, 1993.

    PubMed  CAS  Google Scholar 

  31. Whorwood C.B., Ricketts M.L., Stewart P.M. Epithelial cell localization of type 2 11ß-hydroxysteroid dehydrogenase in rat and human colon. Endocrinology. 135: 2533, 1994.

    PubMed  CAS  Google Scholar 

  32. Brown R.W., Chapman K.E., Edwards C.R.W., Seckl J.R. Human placental 11ß-hydroxysteroid dehydrogenase: evidence for partial purification of a distinct NAD-dependent isoform. Endocrinology. 132: 2614, 1993.

    PubMed  CAS  Google Scholar 

  33. Stewart P.M., Murry B.A., Mason I. Type 2 11ß-hydroxysteroid dehydrogenase in human fetal tissues. J. Clin. Endocrinol. Metab. 78: 1529, 1994.

    PubMed  CAS  Google Scholar 

  34. Albiston A.L., Obeyesekere V.R., Smith R.E., Krozowski Z.S. Cloning and tissue distribution of the human 11ß-hydroxysteroid dehydrogenase type 2 enzyme. Mol. Cell. Endocrinol. 105: R11, 1994.

    PubMed  CAS  Google Scholar 

  35. Agarwal A.K., Mune T., Monder C., White P.C. NAD(+)-dependent isoform of 11beta-hydroxysteroid dehydrogenase. Cloning and characterization of cDNA from sheep kidney. J. Biol. Chem. 269: 25959, 1994.

    CAS  Google Scholar 

  36. Werder E., Zachman M., Vollmin J.A., Veyrat R., Prader A. Unusual steroid excretion in a child with low-renin hypertension. Res. Steroids 6: 385, 1974.

    Google Scholar 

  37. Sann L., Revol A., Zachmann M., Legrand J.C., Bethenod M. Unusual low plasma renin hypertension in a child. J. Clin. Endocrinol. Metab. 43: 265, 1975.

    Google Scholar 

  38. New M.I., Levine L.S., Biglieri E.G., Pareira J., Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J. Clin. Endocrinol. Metab. 44: 924, 1977.

    PubMed  CAS  Google Scholar 

  39. Liddle G.W., Bledsoe T., Coppage W.S. A familial renal disorder simulating primary aldos-teronism but with negligible aldosterone secretion. Trans. Assoc. Am. Physicians. 76: 199, 1963.

    CAS  Google Scholar 

  40. Hyman P.E., Sha’afi R.I., Tan S.Y., Hintz R. Liddle’s syndrome. J. Pediatr. 95: 77, 1979.

    PubMed  CAS  Google Scholar 

  41. Milora R., Vagnucci A., Goodman A.D. A syndrome resembling primary aldosteronism but without mineralocorticoid excess (MCE). Clin. Res. 15: 482, 1967. (abstract)

    Google Scholar 

  42. Helbock H.J., Reynolds J.W. Pseudoaldosteronism (Liddle’s syndrome): evidence for increased cell membrane permeability to Na+. Pediatr. Res. 4: 455, 1970. (abstract)

    Google Scholar 

  43. Shackleton C.H.L., Honour J.W., Dillon M.J., Chantier C., Jones R.W. Hypertension in a four-year-old child; gas chromatographic and mass spectrometric evidence for deficient hepatic metabolism of steroids. J. Clin. Endocrinol. Metab. 50: 786, 1980.

    PubMed  CAS  Google Scholar 

  44. Ulick S., Ramirez L.C., New M.I. An abnormality in steroid reductive metabolism in a hypertensive syndrome. J. Clin. Endocrinol. Metab. 44: 799, 1977.

    PubMed  CAS  Google Scholar 

  45. Marver D., Edelman I.S. Dihydrocortisol: a potential mineralocorticoid. J. Steroid. Biochem. 9: 1, 1978.

    PubMed  CAS  Google Scholar 

  46. Oberfield S.E., Levine L.S., Carey R.M., Greig F., Ulick S., New M.I. Metabolic and blood pressure responses to hydrocortisone in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 56: 332, 1983.

    PubMed  CAS  Google Scholar 

  47. Fiselier T.J.W., Otten B.J., Monnens L.A.H., Honour J.W., van Munster P.J.J. Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month old child. Horm. Res. 16: 107, 1982.

    PubMed  CAS  Google Scholar 

  48. Honour J.W., Dillon M.J., Levin M., Shah V. Fatal, low renin hypertension associated with a disturbance of cortisol metabolism. Arch. Dis. Child. 58: 1018, 1983.

    PubMed Central  PubMed  CAS  Google Scholar 

  49. Harinck H.I.J., van Brummelen P., van Seters A.P., Moolenaar A.J. Apparent mineralocorticoid excess and deficient 11ß-oxidation of cortisol in a young female. Clin. Endocrinol. 21: 505, 1984.

    CAS  Google Scholar 

  50. Shackleton C.H.L., Rodriguez J., Arteaga E., Lopez J.M., Winter J.S.D. Congenital 11ß-hydroxysteroid dehydrogenase deficiency associated with juvenile hypertension: corticosteroid metabolite profiles of four patients and their families. Clin. Endocrinol. 22: 701, 1985.

    CAS  Google Scholar 

  51. Monder C., Shackleton C.H.L., Bradlow H.L., New M.I., Stoner E., Iohan F., Lakshmi V. The syndrome of apparent mineralocorticoid excess: its association with 11ß-dehydrogenase and 5ß-reductase deficiency and some consequences for corticosteroid metabolism. J. Clin. Endocrinol. Metab. 63: 550, 1986.

    PubMed  CAS  Google Scholar 

  52. Dimartino-Nardi J., Stoner E., Martin K., Balfe J.M., Jose P.A., New M.I. New findings in apparent mineralocorticoid excess. Clin. Endocrinol. 27: 49, 1987.

    CAS  Google Scholar 

  53. Nikkilä H., Tannin G.M., New M.I., Taylor N.F., Kalaitzoglou G., Monder C., White P.C. Defect in the HSD11 gene encoding 11ß-hydroxysteroid dehydrogenase are not found in patients with apparent mineralocorticoid excess or 11-oxoreductase deficiency. J. Clin. Endocrinol. Metab. 77: 687, 1993.

    PubMed  Google Scholar 

  54. Batista M.C., Mendonça B.B., Kater C.E., Arnhold I.J.P., Rocha A., Nicolau W., Bloise W. Spironolactone-reversible rickets associated with 11ß-hydroxysteroid dehydrogenase deficiency syndrome. J. Pediatr. 109: 989, 1986.

    PubMed  CAS  Google Scholar 

  55. Milford D.V., Shackleton C.H.L., Stewart P.M. Mineralocorticoid hypertension and congenital deficiency of 11ß-hydroxysteroid dehydrogenase in a family with the syndrome of ‘apparent’ mineralocorticoid excess. Clin. Endocrinol. 42: In press, 1995.

  56. Edwards C.R.W., Stewart P.M., Nairn I.M., Grieve J., Shackleton C.H.L. Cushing’s disease of the kidney. J. Endocrinol. 104 (S): 53, 1985. (abstract).

    Google Scholar 

  57. Stewart P.M., Corrie J.E.T., Shackleton C.H.L., Edwards C.R.W. Syndrome of apparent mineralocorticoid excess a defect in the cortisol-cortisone shuttle. J. Clin. Invest. 82: 340, 1988.

    PubMed Central  PubMed  CAS  Google Scholar 

  58. Ulick S., Tedde R., Mantero F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 70: 200, 1990.

    PubMed  CAS  Google Scholar 

  59. Ulick S., Tedde R., Wang J.Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J. Clin. Endocrinol. Metab. 74: 593, 1992.

    PubMed  CAS  Google Scholar 

  60. Tedde R., Pala A., Melis A., Ulick S. Evidence for cortisol as the mineralocorticoid in the syndrome of apparent mineralocorticoid excess. J. Endocrinol. Invest. 15: 471, 1992.

    PubMed  CAS  Google Scholar 

  61. Mantero F., Tedde R., Opocher G., Dessi Fulgheri P., Amaldi G., Ulick S. Apparent mineralocorticoid excess type II. Steroids 59: 80, 1994.

    PubMed  CAS  Google Scholar 

  62. Speiser P.W., Riddick L.M., Martin K., New M.I. Investigation of the mechanism of hypertension in apparent mineralocorticoid excess. Metabolism 42: 843, 1993.

    PubMed  CAS  Google Scholar 

  63. New M.I. The prismatic case of apparent mineralocorticoid excess J. Clin. Endocrinol. Metab. 79: 1, 1994.

    CAS  Google Scholar 

  64. Winter J.S.D., McKenzie J.K. A syndrome of low-renin hypertension in children. In: New M.I., Levine L.S. (Eds.), Juvenile hypertension. Raven Press, New York, 1977, p. 123.

    Google Scholar 

  65. Savage M.W., Barton R.N., Dornan T.L., Horan M.A., Robins A.J., Taylor N.F. Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency. J. Endocrinol. 129 S): 219, 1991 (abstract).

    Google Scholar 

  66. Taylor N.F., Bartlett W.A., Dawson D.J., Enoch B.A. Cortisone reductase deficiency; evidence for a new inborn error in metabolism of adrenal steroids. J. Endocrinol. 102 (S): 90, 1984 (abstract).

    Google Scholar 

  67. Phillipou G., Higgins B.A. A new defect in the peripheral conversion of cortisone to cortisol. J. Steroid. Biochem. 22: 435, 1985.

    PubMed  CAS  Google Scholar 

  68. Rodin A., Thakkar H., Taylor N., Clayton R. Hyperandrogenism in polycystic ovary syndrome — Evidence of dysregulation of 11ß-hydroxysteroid dehydrogenase. N. Engl. J. Med. 330: 460, 1994.

    PubMed  CAS  Google Scholar 

  69. Davis E.A., Morris D.J. Medicinal uses of licorice through the millennia: the good and plenty of it. Mol. Cell. Endocrinol. 78: 1, 1991.

    PubMed  CAS  Google Scholar 

  70. Reevers F. Behandling van uleus ventriculi in uleus duodeni met succus liquriate. Ned. Tijdschr. Geneesk. 92: 2968, 1946.

    Google Scholar 

  71. Card W.I., Mitchell W., Strong J.A., Taylor N.R.W., Tompsett S.L., Wilson J.M.G. Effects of liquorice and its derivatives on salt and water metabolism. Lancet i: 663, 1953.

    Google Scholar 

  72. Conn J.W., Rovner D.R., Cohen E.L. Licorice-induced pseudoaldosteronism. JAMA 205: 492, 1968.

    PubMed  CAS  Google Scholar 

  73. Epstein M.T., Espiner E.A., Donald R.A., Hughes H. Effect of eating liquorice on the renin-angiotensin aldosterone axis in normal subjects. Br. Med. J. 1: 488, 1977.

    PubMed Central  PubMed  CAS  Google Scholar 

  74. Epstein M.T., Espiner E.A., Donald R.A., Hughes H. Liquorice toxicity and the renin-angiotensin-aldosterone axis in man. Br. Med. J. 1: 209, 1977.

    PubMed Central  PubMed  CAS  Google Scholar 

  75. Blachley J.D., Knochel J.P. Tobacco chewer’s hypokalemia: Licorice revisited. N. Engl. J. Med. 302: 784, 1980.

    PubMed  CAS  Google Scholar 

  76. Salassa R.M., Mattox V.R., Rosevear J.W. Inhibition of the “Mineralocorticoid” activity of licorice by spironolactone. J. Clin. Endocrinol. Metab. 22: 1156, 1962.

    PubMed  CAS  Google Scholar 

  77. Turpie A.G.G., Thomson T.J. Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects. Gut 5: 591, 1965.

    Google Scholar 

  78. Ulmann A., Menard J., Corvol P. Binding of glycyrrhetinic acid to kidney mineralocorticoid and glucocorticoid receptors. Endocrinology 97: 46, 1975.

    PubMed  CAS  Google Scholar 

  79. Armanini D., Karbowiak I., Krozowski Z., Funder J.W., Adam W.R. The mechanism of mineralocorticoid action of carbenoxolone. Endocrinology 111: 1683, 1982.

    PubMed  CAS  Google Scholar 

  80. Armanini D., Karbowiak I., Funder J.W. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. Clin. Endocrinol. 19: 609, 1983.

    CAS  Google Scholar 

  81. Louis L.H., Conn J.W. Preparation of glycyrrhizinic acid, the electrolyte-active principle of licorice: its effects upon metabolism and upon pituitary-adrenal function in man. J. Lab. Clin. Med. 47: 20, 1956.

    PubMed  CAS  Google Scholar 

  82. Elmadjian F., Hope J.M., Pincus G. The action of mono-ammonium glycyrrhizinate on adrenalectomized subjects and its synergism with hydrocortisone. J. Clin. Endocrinol. Metab. 16: 338, 1956.

    PubMed  CAS  Google Scholar 

  83. Borst J.G.G., Ten Holt S.P., De Vries L.A., Molhuysen L.A. Synergistic action of liquorice and cortisone in Addison’s and Simmonds’s disease. Lancet i: 657, 1953.

    Google Scholar 

  84. Girerd R.J., Rassaert C.L., DiPasquale G., Kroc R.L. Endocrine involvement in licorice hypertension. Am. J. Physiol. 198: 718, 1960.

    PubMed  CAS  Google Scholar 

  85. Groen J., Pelser H., Willebrands A.F., Kamminga C.E. Extract of licorice for the treatment of Addison’s disease. N. Engl. J. Med. 244: 471, 1951.

    PubMed  CAS  Google Scholar 

  86. Groen J., Pelser H., Frenkel M., Kamminga C.E., Willebrands A.F. Effect of glycyrrhizinic acid on the electrolyte metabolism in Addison’s disease. J. Clin. Invest. 31: 87, 1952.

    PubMed Central  PubMed  CAS  Google Scholar 

  87. Epstein M.T., Espiner E.A., Donald R.A., Hughes H., Cowles R.J., Lun S. Licorice raises urinary cortisol in man. J. Clin. Endocrinol. Metab. 47: 397, 1978.

    PubMed  CAS  Google Scholar 

  88. Monder C., Stewart P.M., Lakshmi V., Valentino R., Burt D., Edwards C.R.W. Licorice inhibits corticosteroid 11ß-dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125: 1046, 1989.

    PubMed  CAS  Google Scholar 

  89. Souness G.W., Morris D.J. The antinatriuretic and kaliuretic effects of the glucocorticoids corticosterone and cortisol following pretreatment with carbenoxolone sodium (a liquorice derivative) in the adrenalectomized rat. Endocrinology 124: 1588, 1989.

    PubMed  CAS  Google Scholar 

  90. Stewart P.M., Wallace A.M., Valentino R., Burt D., Shackleton C.H.L., Edwards C.R.W. Mineralocorticoid activity of liquolice: 11-ß-hydroxysteroid dehydrogenase deficiency comes of age. Lancet ii: 821, 1987.

    Google Scholar 

  91. MacKenzie M.A., Hoefnagels W.H.L., Jansen R.W.M.M., Benraad T.J., Kloppenborg P.W.C. The influence of glycyrrhetinic acid on plasma cortisol and cortisone in healthy young volunteers. J. Clin. Endocrinol. Metab. 70: 1637, 1990.

    PubMed  CAS  Google Scholar 

  92. Farese R.V., Biglieri E.G., Shackleton C.H.L., Irony I., Gomez-Fontes R. Licorice-induced hypermineralocorticoidism. N. Engl. J. Med. 325: 1223, 1991.

    PubMed  Google Scholar 

  93. Kageyama Y., Suzuki H., Saruta T. Glycyrrhizin induces mineralocorticoid activity through alterations in cortisol metabolism in the human kidney. J. Endocrinol. 135: 147, 1992.

    PubMed  CAS  Google Scholar 

  94. Souness G.W., Morris D. The “mineralocorticoid-like” actions conferred on corticosterone by carbenoxolone are inhibited by the mineralocorticoid receptor (type I) antagonist RU28318. Endocrinology 129: 2451, 1991.

    PubMed  CAS  Google Scholar 

  95. Whorwood C.B., Sheppard M.C., Stewart P.M. Licorice inhibits 11ß-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology 132: 2287, 1993.

    PubMed  CAS  Google Scholar 

  96. Stewart P.M., Whorwood C.B. 11ß-hydroxysteroid dehydrogenase activity and corticosteroid hormone action. Steroids 59: 90, 1994.

    PubMed  CAS  Google Scholar 

  97. Monder C. Corticosteroids, kidneys, sweet roots and dirty drugs. Mol. Cell. Endocrinol. 78: C95, 1991.

    PubMed  CAS  Google Scholar 

  98. Sheppard K., Funder J.W. Mineralocorticoid specificity of renal type I receptors: in vivo binding studies. Am. J. Physiol. 252: E224, 1987.

    PubMed  CAS  Google Scholar 

  99. Stephenson G., Krozowski Z., Funder J.W. Extravascular CBG-like sites in rat kidney and mineralocorticoid receptor specificity. Am. J. Physiol. 246: F227, 1984.

    PubMed  CAS  Google Scholar 

  100. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid actin: target tissue specificity is enzyme, not receptor, mediated. Science 242: 583, 1988.

    PubMed  CAS  Google Scholar 

  101. Walker B.R., Stewart P.M., Shackleton C.H.L., Padfield P.L., Edwards C.R.W. Deficient inactivation of cortisol by 11ß-hydroxysteroid dehydrogenase in essential hypertension. Clin. Endocrinol. 39: 221, 1993.

    CAS  Google Scholar 

  102. Walker B.R., Yau J.L., Brett L.P., Seckl J.R., Monder C., Williams B.C., Edwards C.R.W. 11ß-hydroxysteroid dehydrogenase in vascular smooth muscle and heart: implications for cardiovascular responses to glucocorticoids. Endocrinology 129: 3305, 1991.

    PubMed  CAS  Google Scholar 

  103. Walker B.R., Connacher A.A., Webb D.J., Edwards C.R.W. Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man. Clin. Sci. 83: 171, 1992.

    PubMed  CAS  Google Scholar 

  104. Edwards C.R.W., Benediktsson R., Lindsay R.S., Seckl J.R. Dysfunction of placental glucocorticoid barrier: link between fetal environment and adult hypertension? Lancet 341: 355, 1993.

    PubMed  CAS  Google Scholar 

  105. Benediktsson R., Lindsay R.S., Noble J., Seckl J.R., Edwards C.R.W. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet 341: 339, 1993.

    PubMed  CAS  Google Scholar 

  106. Morris D.J., Semafuko W.E.B., Latif S.A., Vogel B., Grimes C.A., Sheff M.F. Detection of glycyrrhetinic acid-like factors (GALFs) in human urine. Hypertension 20: 356, 1992.

    PubMed  CAS  Google Scholar 

  107. Walker B.R., Agarwal I., Stewart P.M., Padfield P.L., Edwards C.R.W. Endogenous inhibitors of 11ß-hydroxysteroid dehydrogenase in hypertension. J. Clin. Endocrinol. Metab. 80: 529, 1995.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, England

    M. Shimojo & Paul M. Stewart M.D.

Authors
  1. M. Shimojo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul M. Stewart M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shimojo, M., Stewart, P.M. Apparent mineralocorticoid excess syndromes. J Endocrinol Invest 18, 518–532 (1995). https://doi.org/10.1007/BF03349763

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349763

Keywords

Search

Navigation